Mendoza-Soto, P.; Jara, C.; Torres-Arévalo, Á.; Oyarzún, C.; Mardones, G.A.; Quezada-Monrás, C.; San Martín, R.
Pharmacological Blockade of the Adenosine A2B Receptor Is Protective of Proteinuria in Diabetic Rats, through Affecting Focal Adhesion Kinase Activation and the Adhesion Dynamics of Podocytes. Cells 2024, 13, 846.
https://doi.org/10.3390/cells13100846
AMA Style
Mendoza-Soto P, Jara C, Torres-Arévalo Á, Oyarzún C, Mardones GA, Quezada-Monrás C, San Martín R.
Pharmacological Blockade of the Adenosine A2B Receptor Is Protective of Proteinuria in Diabetic Rats, through Affecting Focal Adhesion Kinase Activation and the Adhesion Dynamics of Podocytes. Cells. 2024; 13(10):846.
https://doi.org/10.3390/cells13100846
Chicago/Turabian Style
Mendoza-Soto, Pablo, Claudia Jara, Ángelo Torres-Arévalo, Carlos Oyarzún, Gonzalo A. Mardones, Claudia Quezada-Monrás, and Rody San Martín.
2024. "Pharmacological Blockade of the Adenosine A2B Receptor Is Protective of Proteinuria in Diabetic Rats, through Affecting Focal Adhesion Kinase Activation and the Adhesion Dynamics of Podocytes" Cells 13, no. 10: 846.
https://doi.org/10.3390/cells13100846
APA Style
Mendoza-Soto, P., Jara, C., Torres-Arévalo, Á., Oyarzún, C., Mardones, G. A., Quezada-Monrás, C., & San Martín, R.
(2024). Pharmacological Blockade of the Adenosine A2B Receptor Is Protective of Proteinuria in Diabetic Rats, through Affecting Focal Adhesion Kinase Activation and the Adhesion Dynamics of Podocytes. Cells, 13(10), 846.
https://doi.org/10.3390/cells13100846
